Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer

Xuan-Yu Hu, Zhe-Nan Ling, Lian-Lian Hong, Qi-Ming Yu, Pei Li, Zhi-Qiang Ling, Xuan-Yu Hu, Zhe-Nan Ling, Lian-Lian Hong, Qi-Ming Yu, Pei Li, Zhi-Qiang Ling

Abstract

Objectives: Thrombospondin 1 (THBS1) is known to play a key role in tumor metastasis, and aberrant DNA methylation is one of the mechanisms regulating THBS1. The present study investigated whether methylated THBS1 in circulating cell-free DNA from preoperative peritoneal lavage fluid (PPLF) and peripheral blood could be used as a potential biomarker for predicting peritoneal dissemination in gastric cancer (GC) patients.

Methods: The status of THBS1 methylation was detected by quantitative methylation-specific PCR (MSP) in tumor tissues, paired PPLF, and serum from 92 GC patients. The correlation between methylated THBS1 levels and peritoneal dissemination of GC was studied, and its diagnostic value for predicting peritoneal dissemination was clarified by the receiver operating characteristic (ROC) curve.

Results: Aberrant THBS1 methylation in tumor tissues was significantly higher than that in paracancerous normal tissues (p < 0.0001). No THBS1 methylation was found in 40 healthy controls, and partial methylation was detected in 3 of 48 patients with chronic non-atrophic gastritis. The frequency of THBS1 methylation in pairing PPLF and serum from 92 GC patients was 52.2% (48/92) and 58.7% (54/92), respectively. The results of methylated THBS1 in pairing PPLF and serum were similar to those of tumor tissues. Aberrant THBS1 methylation in tumor tissues and pairing PPLF or serum was closely related to peritoneal dissemination, tumor progression, and poor prognosis (all p < 0.0001).

Conclusion: Circulating methylated THBS1 DNAs in PPLF/serum may predict peritoneal dissemination, a potential poor prognostic factor for GC patients.

Keywords: THBS1 gene; gastric carcinoma; methylation; peritoneal dissemination; prognosis.

Conflict of interest statement

This study is not related to any potentially competing financial or other interests.

© 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.

Figures

FIGURE 1
FIGURE 1
Comparison of THBS1 methylation in GC tissues, paired preoperative peritoneal lavage fluid (PPLF), and serum samples (T: tumor tissues; P: preoperative peritoneal lavage fluid (PPLF); and S: serum). The figure only showed % methylation of tumor tissue in GC, and Ⅰ‐Ⅳ represent the clinical staging
FIGURE 2
FIGURE 2
Correlation analysis of THBS1 methylation results between GC tissues and paired PPLF or paired serum (A: correlation of THBS1 methylation results between GC tissues and paired PPLF (γ = 0.9673, p < 0.0001); B: correlation of THBS1 methylation results between GC tissues and paired serum (γ = 0.9521, p < 0.0001))
FIGURE 3
FIGURE 3
Diagnostic value of THBS1 methylation in GC tissues, PPLF, and serum for the peritoneal dissemination of GC and its effect on patient prognosis (A–C): The diagnostic value of THBS1 methylation in GC tissues, paired PPLF, and serum for peritoneal dissemination of GC was determined by ROC curves, of which the Aζ value of the ROC curve was 0.8234 for GC tissues, 0.8331 for PPLF, and 0.8053 for serum compared with positive PPLF cytology. (D–F): THBS1 methylation in GC tissues, PPLF, and serum correlated with patient prognosis. Cumulative DFS curves were plotted against THBS1 methylation level in GC tissues (D), PPLF (E), and serum (F). In D, E, and F, Kaplan‐Meier analysis was used, and all parameters were p < 0.0001

References

    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. 10.3322/caac.21660
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394‐424.
    1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115‐132.
    1. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R. Cancer of the stomach. a patient care study by the American college of surgeons. Ann Surg. 1993;218(5):583‐592.
    1. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87(2):236‐242.
    1. Fujiwara Y, Doki Y, Taniguchi H, et al. Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives. Gastric Cancer. 2007;10(4):197‐204.
    1. Virgilio E, Giarnieri E, Giovagnoli MR, et al. Gastric cancer cells in peritoneal lavage fluid: a systematic review comparing cytological with molecular detection for diagnosis of peritoneal metastases and prediction of peritoneal recurrences. Anticancer Res. 2018;38(3):1255‐1262.
    1. Kanetaka K, Ito S, Susumu S, et al. Clinical significance of carcinoembryonic antigen in peritoneal lavage from patients with gastric cancer. Surgery. 2013;154(3):563‐572.
    1. Nakabayashi K, Uraoka T, Shibuya M, Matsuura N, Tsujimoto M. Rapid detection of CEA mRNA in peritoneal washes using one‐step nucleic acid amplification (OSNA®) for gastric cancer patients. Clin Chim Acta. 2015;439:137‐142.
    1. Huang C, Liu Z, Xiao LI, et al. Clinical significance of serum CA125, CA19‐9, CA72‐4, and fibrinogen‐to‐lymphocyte ratio in gastric cancer with peritoneal dissemination. Front Oncol. 2019;9:e1159.
    1. Kodera Y, Nakanishi H, Ito S, et al. Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen. Gastric Cancer. 2005;8(3):142‐148.
    1. Lorenzen S, Panzram B, Rosenberg R, et al. Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection. Ann Surg Oncol. 2010;17(10):2733‐2739.
    1. Yonemura Y, Fujimura T, Ninomiya I, et al. Prediction of peritoneal micrometastasis by peritoneal lavaged cytology and reverse transcriptase‐ polymerase chain reaction for matrix metalloproteinase‐7 mRNA. Clin Cancer Res. 2001;7(6):1647‐1653.
    1. Dalal KM, Woo Y, Kelly K, et al. Detection of micrometastases in peritoneal washings of gastric cancer patients by the reverse transcriptase polymerase chain reaction. Gastric Cancer. 2008;11(4):206‐213.
    1. Mori K, Suzuki T, Uozaki H, et al. Detection of minimal gastric cancer cells in peritoneal washings by focused microarray analysis with multiple markers: clinical implications. Ann Surg Oncol. 2007;14(5):1694‐1702.
    1. Iida T, Iwahashi M, Katsuda M, et al. Prognostic significance of IL‐17 mRNA expression in peritoneal lavage in gastric cancer patients who underwent curative resection. Oncol Rep. 2014;31(2):605‐612.
    1. Zavridou M, Mastoraki S, Strati A, Tzanikou E, Chimonidou M, Lianidou E. Evaluation of preanalytical conditions and implementation of quality control steps for reliable gene expression and DNA methylation analyses in liquid biopsies. Clin Chem. 2018;64(10):1522‐1533.
    1. Zavridou M, Strati A, Bournakis E, Smilkou S, Tserpeli V, Lianidou E. Prognostic significance of gene expression and DNA methylation markers in circulating tumor cells and paired plasma derived exosomes in metastatic castration resistant prostate cancer. Cancers (Basel). 2021;13(4):780.
    1. Mastoraki S, Strati A, Tzanikou E, et al. ESR1 Methylation: a liquid biopsy‐based epigenetic assay for the follow‐up of patients with metastatic breast cancer receiving endocrine treatment. Clin Cancer Res. 2018;24(6):1500‐1510.
    1. Yu J‐L, Lv P, Han J, et al. Methylated TIMP‐3 DNA in body fluids is an independent prognostic factor for gastric cancer. Arch Pathol Lab Med. 2014;138(11):1466‐1473.
    1. Han J, Lv P, Yu J‐L, et al. Circulating methylated MINT2 promoter DNA is a potential poor prognostic factor in gastric cancer. Dig Dis Sci. 2014;59(6):1160‐1168.
    1. Ling ZQ, Lv P, Lu XX, et al. Circulating methylated XAF1 DNA indicates poor prognosis for gastric cancer. PLoS One. 2013;8(6):e67195.
    1. Lu XX, Yu JL, Ying LS, et al. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Cancer. 2012;118(22):5507‐5517.
    1. Yu QM, Wang XB, Luo J, et al. CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer. J Surg Oncol. 2012;106(6):765‐771.
    1. Ling ZQ, Zhao Q, Zhou SL, Mao WM. MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease‐free survival for patients with esophageal squamous cell carcinoma. Eur J Surg Oncol. 2012;38(4):326‐332.
    1. Silverstein RL, Febbraio M. CD36‐TSP‐HRGP interactions in the regulation of angiogenesis. Curr Pharm Des. 2007;13(35):3559‐3567.
    1. Yee KO, Connolly CM, Duquette M, Kazerounian S, Washington R, Lawler J. The effect of thrombospondin‐1 on breast cancer metastasis. Breast Cancer Res Treat. 2009;114(1):85‐96.
    1. Lin XD, Chen SQ, Qi YL, Zhu JW, Tang Y, Lin JY. Overexpression of thrombospondin‐1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma. J Surg Oncol. 2012;106(1):94‐100.
    1. Kasper HU, Ebert M, Malfertheiner P, Roessner A, Kirkpatrick CJ, Wolf HK. Expression of thrombospondin‐1 in pancreatic carcinoma: correlation with microvessel density. Virchows Arch. 2001;438(2):116‐120.
    1. Kazerounian S, Yee KO, Lawler J. Thrombospondins in cancer. Cell Mol Life Sci. 2008;65(5):700‐712.
    1. Rojas A, Meherem S, Kim YH, et al. The aberrant methylation of TSP1 suppresses TGF‐beta1 activation in colorectal cancer. Int J Cancer. 2008;123(1):14‐21.
    1. Lindner DJ, Wu Y, Haney R, et al. Thrombospondin‐1 expression in melanoma is blocked by methylation and targeted reversal by 5‐Aza‐deoxycytidine suppresses angiogenesis. Matrix Biol. 2013;32(2):123‐132.
    1. Guo W, Dong Z, He M, et al. Aberrant methylation of thrombospondin‐1 and its association with reduced expression in gastric cardia adenocarcinoma. J Biomed Biotechnol. 2010;2010:721485.
    1. Sicinschi LA, Correa P, Peek RM, et al. Helicobacter pylori genotyping and sequencing using paraffin‐embedded biopsies from residents of Colombian areas with contrasting gastric cancer risks. Helicobacter. 2008;13(2):135‐145.
    1. van Doorn LJ, Figueiredo C, Rossau R, et al. Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J Clin Microbiol. 1998;36(5):1271‐1276.
    1. Ho SA, Hoyle JA, Lewis FA, et al. Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol. 1991;29(11):2543‐2549.
    1. Huang C, Zhou X, Li Z, et al. Downregulation of thrombospondin‐1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma. Mol Med Rep. 2016;14(3):2489‐2496.
    1. Chen Y, Zhou Q, Wang H, et al. Predicting peritoneal dissemination of gastric cancer in the era of precision medicine: molecular characterization and biomarkers. Cancers (Basel). 2020;12(8):2236.
    1. Lo YMD, Han DSC, Jiang P, et al. Epigenetics, fragmentomics, and topology of cell‐free DNA in liquid biopsies. Science. 2021;372(6538):eaaw3616.
    1. Kanyama Y, Hibi K, Nakayama H, et al. Detection of p16 promoter hypermethylation in serum of gastric cancer patients. Cancer Sci. 2003;94(5):418‐420.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다